These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 33423829)
1. Application of CMAP scan for the evaluation of patients with chronic inflammatory demyelinating polyneuropathy: a prospective study. Okhovat AA; Advani S; Moradi K; Ziaadini B; Panahi A; Nafissi S; Haghi Ashtiani B; Fatehi F Neurophysiol Clin; 2021 Mar; 51(2):175-181. PubMed ID: 33423829 [TBL] [Abstract][Full Text] [Related]
2. Changes of clinical, neurophysiological and nerve ultrasound characteristics in CIDP over time: a 3-year follow-up. Fionda L; Di Pasquale A; Morino S; Leonardi L; Vanoli F; Loreti S; Garibaldi M; Lauletta A; Alfieri G; Bucci E; Salvetti M; Antonini G J Neurol; 2021 Aug; 268(8):3011-3019. PubMed ID: 33638679 [TBL] [Abstract][Full Text] [Related]
3. The value of MUNIX as an objective electrophysiological biomarker of disease progression in chronic inflammatory demyelinating polyneuropathy. Okhovat AA; Advani S; Ziaadini B; Panahi A; Salehizadeh S; Nafissi S; Haghi Ashtiani B; Rajabally YA; Fatehi F Muscle Nerve; 2022 Apr; 65(4):433-439. PubMed ID: 35040150 [TBL] [Abstract][Full Text] [Related]
4. Which nerve conduction parameters can predict spontaneous electromyographic activity in carpal tunnel syndrome? Chang CW; Lee WJ; Liao YC; Chang MH Clin Neurophysiol; 2013 Nov; 124(11):2264-8. PubMed ID: 23763989 [TBL] [Abstract][Full Text] [Related]
5. Compound muscle action potential duration ratio for differentiation between Charcot-Marie-Tooth disease and CIDP. Kitaoji T; Noto YI; Kojima Y; Tsuji Y; Kitani-Morii F; Mizuno T; Nakagawa M Clin Neurophysiol; 2023 Feb; 146():124-130. PubMed ID: 36608530 [TBL] [Abstract][Full Text] [Related]
6. Activity-dependent hyperpolarization and conduction block in chronic inflammatory demyelinating polyneuropathy. Cappelen-Smith C; Kuwabara S; Lin CS; Mogyoros I; Burke D Ann Neurol; 2000 Dec; 48(6):826-32. PubMed ID: 11117538 [TBL] [Abstract][Full Text] [Related]
7. Axonal damage determines clinical disability in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): A prospective cohort study of different CIDP subtypes and disease stages. Grüter T; Motte J; Bulut Y; Kordes A; Athanasopoulos D; Fels M; Schneider-Gold C; Gold R; Fisse AL; Pitarokoili K Eur J Neurol; 2022 Feb; 29(2):583-592. PubMed ID: 34687104 [TBL] [Abstract][Full Text] [Related]
8. Criteria for demyelination based on the maximum slowing due to axonal degeneration, determined after warming in water at 37 degrees C: diagnostic yield in chronic inflammatory demyelinating polyneuropathy. Van Asseldonk JT; Van den Berg LH; Kalmijn S; Wokke JH; Franssen H Brain; 2005 Apr; 128(Pt 4):880-91. PubMed ID: 15689367 [TBL] [Abstract][Full Text] [Related]
9. Electrophysiological testing in chronic inflammatory demyelinating polyneuropathy patients treated with subcutaneous immunoglobulin: The Polyneuropathy And Treatment with Hizentra (PATH) study. Bril V; Hartung HP; Lawo JP; Durn BL; Mielke O Clin Neurophysiol; 2021 Jan; 132(1):226-231. PubMed ID: 33039291 [TBL] [Abstract][Full Text] [Related]
10. Distribution, clinical correlates and significance of axonal loss and demyelination in chronic inflammatory demyelinating polyneuropathy. Rajabally YA; Narasimhan M Eur J Neurol; 2011 Feb; 18(2):293-299. PubMed ID: 20602631 [TBL] [Abstract][Full Text] [Related]
11. Different Tendencies in Muscle Ultrasound Characteristic in Amyotrophic Lateral Sclerosis and Chronic Inflammatory Demyelinating Polyradiculoneuropathy. Hokkoku K; Tsukamoto H; Uchida Y; Gatto DM; Sonoo M J Clin Neurophysiol; 2023 Jul; 40(5):450-455. PubMed ID: 37399044 [TBL] [Abstract][Full Text] [Related]
12. Conduction block during and after ischaemia in chronic inflammatory demyelinating polyneuropathy. Cappelen-Smith C; Lin CS; Kuwabara S; Burke D Brain; 2002 Aug; 125(Pt 8):1850-8. PubMed ID: 12135975 [TBL] [Abstract][Full Text] [Related]